Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank7
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-28.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -8.61% |
| 2024 | 16.34% |
| 2023 | 20.02% |
| 2022 | 15.95% |
| 2021 | 35.58% |
| 2020 | 0.31% |
| 2019 | -13.77% |
| 2018 | 17.86% |
| 2017 | 12.12% |
| 2016 | 40.45% |